525 related articles for article (PubMed ID: 33218968)
1. Myeloma-Modified Adipocytes Exhibit Metabolic Dysfunction and a Senescence-Associated Secretory Phenotype.
Fairfield H; Dudakovic A; Khatib CM; Farrell M; Costa S; Falank C; Hinge M; Murphy CS; DeMambro V; Pettitt JA; Lary CW; Driscoll HE; McDonald MM; Kassem M; Rosen C; Andersen TL; van Wijnen AJ; Jafari A; Reagan MR
Cancer Res; 2021 Feb; 81(3):634-647. PubMed ID: 33218968
[TBL] [Abstract][Full Text] [Related]
2. Myeloma-bone marrow adipocyte axis in tumour survival and treatment response.
Jafari A; Fairfield H; Andersen TL; Reagan MR
Br J Cancer; 2021 Sep; 125(6):775-777. PubMed ID: 33859343
[TBL] [Abstract][Full Text] [Related]
3. The role of bone marrow adipocytes in cancer progression: the impact of obesity.
Hernandez M; Shin S; Muller C; Attané C
Cancer Metastasis Rev; 2022 Sep; 41(3):589-605. PubMed ID: 35708800
[TBL] [Abstract][Full Text] [Related]
4. Myeloma Cells Down-Regulate Adiponectin in Bone Marrow Adipocytes Via TNF-Alpha.
Morris EV; Suchacki KJ; Hocking J; Cartwright R; Sowman A; Gamez B; Lea R; Drake MT; Cawthorn WP; Edwards CM
J Bone Miner Res; 2020 May; 35(5):942-955. PubMed ID: 31886918
[TBL] [Abstract][Full Text] [Related]
5. Mature adipocytes in bone marrow protect myeloma cells against chemotherapy through autophagy activation.
Liu Z; Xu J; He J; Liu H; Lin P; Wan X; Navone NM; Tong Q; Kwak LW; Orlowski RZ; Yang J
Oncotarget; 2015 Oct; 6(33):34329-41. PubMed ID: 26455377
[TBL] [Abstract][Full Text] [Related]
6. Oxylipin-PPARγ-initiated adipocyte senescence propagates secondary senescence in the bone marrow.
Liu X; Gu Y; Kumar S; Amin S; Guo Q; Wang J; Fang CL; Cao X; Wan M
Cell Metab; 2023 Apr; 35(4):667-684.e6. PubMed ID: 37019080
[TBL] [Abstract][Full Text] [Related]
7. Adipocyte-Lineage Cells Support Growth and Dissemination of Multiple Myeloma in Bone.
Trotter TN; Gibson JT; Sherpa TL; Gowda PS; Peker D; Yang Y
Am J Pathol; 2016 Nov; 186(11):3054-3063. PubMed ID: 27648615
[TBL] [Abstract][Full Text] [Related]
8. Adipokines, adiposity, and bone marrow adipocytes: Dangerous accomplices in multiple myeloma.
Morris EV; Edwards CM
J Cell Physiol; 2018 Dec; 233(12):9159-9166. PubMed ID: 29943829
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow adipocytes provide early sign for progression from MGUS to multiple myeloma.
El-Masri BM; Leka B; Mustapha F; Gundesen MT; Hinge M; Lund T; Andersen TL; Diaz-delCastillo M; Jafari A
Oncotarget; 2024 Jan; 15():20-26. PubMed ID: 38227739
[TBL] [Abstract][Full Text] [Related]
10. Abnormalities of bone marrow mesenchymal cells in multiple myeloma patients.
Wallace SR; Oken MM; Lunetta KL; Panoskaltsis-Mortari A; Masellis AM
Cancer; 2001 Apr; 91(7):1219-30. PubMed ID: 11283920
[TBL] [Abstract][Full Text] [Related]
11. Development of a 3D bone marrow adipose tissue model.
Fairfield H; Falank C; Farrell M; Vary C; Boucher JM; Driscoll H; Liaw L; Rosen CJ; Reagan MR
Bone; 2019 Jan; 118():77-88. PubMed ID: 29366838
[TBL] [Abstract][Full Text] [Related]
12. Critical Assessment of In Vitro and In Vivo Models to Study Marrow Adipose Tissue.
Reagan MR
Curr Osteoporos Rep; 2020 Apr; 18(2):85-94. PubMed ID: 32124181
[TBL] [Abstract][Full Text] [Related]
13. Bone Marrow Adiposity in Models of Radiation- and Aging-Related Bone Loss Is Dependent on Cellular Senescence.
Chandra A; Lagnado AB; Farr JN; Schleusner M; Monroe DG; Saul D; Passos JF; Khosla S; Pignolo RJ
J Bone Miner Res; 2022 May; 37(5):997-1011. PubMed ID: 35247283
[TBL] [Abstract][Full Text] [Related]
14. The adipose organ and multiple myeloma: Impact of adipokines on tumor growth and potential sites for therapeutic intervention.
Allegra A; Innao V; Gerace D; Allegra AG; Vaddinelli D; Bianco O; Musolino C
Eur J Intern Med; 2018 Jul; 53():12-20. PubMed ID: 29859797
[TBL] [Abstract][Full Text] [Related]
15. Preclinical studies in support of defibrotide for the treatment of multiple myeloma and other neoplasias.
Mitsiades CS; Rouleau C; Echart C; Menon K; Teicher B; Distaso M; Palumbo A; Boccadoro M; Anderson KC; Iacobelli M; Richardson PG
Clin Cancer Res; 2009 Feb; 15(4):1210-21. PubMed ID: 19228727
[TBL] [Abstract][Full Text] [Related]
16. Adipose, Bone, and Myeloma: Contributions from the Microenvironment.
McDonald MM; Fairfield H; Falank C; Reagan MR
Calcif Tissue Int; 2017 May; 100(5):433-448. PubMed ID: 27343063
[TBL] [Abstract][Full Text] [Related]
17. Organotypic culture of human bone marrow adipose tissue.
Uchihashi K; Aoki S; Shigematsu M; Kamochi N; Sonoda E; Soejima H; Fukudome K; Sugihara H; Hotokebuchi T; Toda S
Pathol Int; 2010 Apr; 60(4):259-67. PubMed ID: 20403027
[TBL] [Abstract][Full Text] [Related]
18. Update on the Role of Glucocorticoid Signaling in Osteoblasts and Bone Marrow Adipocytes During Aging.
Bensreti H; Alhamad DW; Gonzalez AM; Pizarro-Mondesir M; Bollag WB; Isales CM; McGee-Lawrence ME
Curr Osteoporos Rep; 2023 Feb; 21(1):32-44. PubMed ID: 36564571
[TBL] [Abstract][Full Text] [Related]
19. High-Fat Diet-Induced Obesity Promotes Expansion of Bone Marrow Adipose Tissue and Impairs Skeletal Stem Cell Functions in Mice.
Tencerova M; Figeac F; Ditzel N; Taipaleenmäki H; Nielsen TK; Kassem M
J Bone Miner Res; 2018 Jun; 33(6):1154-1165. PubMed ID: 29444341
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow adiposity and multiple myeloma.
Morris EV; Edwards CM
Bone; 2019 Jan; 118():42-46. PubMed ID: 29548987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
